Well, you see here even long term holders talking about taking profits because the price has gone up 3 fold in recent times. That's a reasonable reason for some types of investors/traders to take profits based on their portfolio allocations or trading style. Once those are finished (which it appears close) then the price will go on to reflect a risk-based DCF valuation based on a aGVHD approval. Right now, imo, there is there is too much discounting for a 3rd CRL.
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-704
-
- There are more pages in this discussion • 393 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.38 |
Change
-0.080(5.50%) |
Mkt cap ! $1.569B | |||
| Open | High | Low | Value | Volume |
| $1.43 | $1.43 | $1.37 | $5.321M | 3.829M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 12214 | $1.38 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.38 | 37660 | 5 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |